El cáncer de pulmón aumenta en mujeres y arrasa en España. En la red SOSCLC.ORG trabajaremos en las bases científicas y las implicaciones sociales de este problema!
www.eldiario.es/sociedad/can...

2024 approvals: Summary of 14 new drugs/indications in #LungCancer by FDA

1. #Tepotinib
2. #Osimertinib x2
3. #Alectinib
4. #Tarlatamab
5. #Zenocutuzumab
6. #Durvalumab x2
7. #Amivantamab x2
8. #Nivolumab (now SubQ)
9. #Ensartinib

#lcsm #OncSky #MedSky #Cancer

5 papers about Lung Cancer suggested by Stephen Liu
@stephenvliu.bsky.social

oncodaily.com/science/step...

#Cancer #GeorgetownUniversity #LungCancer #Nivolumab #NSCLC #OncoDaily #Oncology #Osimertinib #Health #PATHER2study #SCLC #TimeToxicity #Medicine

Our lab malumbreslab.org @vhio.bsky.social will join CIBERONC in 2025. Thanks for counting on us!! www.ciberonc.es/en

@casanova-acebes.bsky.social, a member of the @sosclc-aecc.bsky.social, receives an ERC grant to improve cancer therapies! elpais.com/salud-y-bien...

Follow our #SLCL starter pack for more news on #lung #cancer #oncosky #oncsky 🧪

Our @sosclc-aecc.bsky.social researcher @crismayorruiz.bsky.social reports a new therapeutic strategy against #lung #cancer. A perfect example of the ideas to be developed within the #SCLC network! #oncosky #oncsky 🧪

Real-world analysis of 1L carboplatin, etoposide, atezolizumab for extensive stage #SCLC with ≥3y f/u published in Lung Cancer. In 207 pts, the 3y OS rate was 21%. Need to build on this backbone, but long-term survival is possible for some. #LCSM #OncSky

www.lungcancerjournal.info/article/S016...

The OncoAlert 🚨Newsletter NOW OUT Covering September November 28-Dec 5, 2024

REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0

✅FDA Approves Duvalumab in #SCLC 🫁🇺🇸
✅FDA ACCELERATED APPROVAL TO
ZENOCUTUZUMAB-ZBCO IN #NSCLC 🫁
✅Lung adenocarcinomas with mucinous & more

A starter pack with researchers, clinicians, associations and patients wirh interest in Small Cell Lung Cancer #SCLC and related lung neuroendocrine tumors. Please contact us if interested in being included or have any suggestion go.bsky.app/HmjASG1

Living with lung cancer isn’t just about battling a disease; it’s about navigating an entirely different reality. These quotes are a glimpse into the struggles, fears, and uncertainties faced by those living with young lung cancer every day. 💔

#LivingWithLungCancer #CancerAdvocacy #lcsm

@sosclc-aecc.bsky.social researcher Dolores Isla talks in El Mundo about current challenges in lung cancer..

A Starter Pack with Small Cell Lung Cancer #SCLC accounts!
#oncsky #oncosky 🧪

Done!!

Done!! 😁

A starter pack with researchers, clinicians, associations and patients wirh interest in Small Cell Lung Cancer #SCLC and related lung neuroendocrine tumors. Please contact us if interested in being included or have any suggestion go.bsky.app/HmjASG1

Why #lungcancer (the #1 cancer killer) needs more funding and research:
Only 2 of the 7 LC patient advocates in this 2018 photo are still alive (including me). While newer treatments like targeted therapy and immune checkpoint inhibitors are effective for some, they don't work for all. #LCSM

New therapies in SCLC: FDA approves durvalumab for limited-stage small cell lung cancer
www.fda.gov/drugs/resour...

An insightful review on genetics and resistance to immunotherapies in cancer by @sosclc-aecc.bsky.social researcher @franmj88.bsky.social @vhio.bsky.social www.cell.com/trends/cance...

2 new studies in Nature reveal how isoprene—a gas from plants—forms particles in the upper atmosphere, improving climate models. Better understanding of air quality & particle behaviour could aid future research into impacts on lung health inclu. #lungcancer #LCSM

www.nature.com/nature/volum...